Ginkgo Bioworks CEO on the business of programmable DNA
26,684
2021-09-17に共有
» Subscribe to CNBC TV: cnb.cx/SubscribeCNBCtelevision
» Subscribe to CNBC: cnb.cx/SubscribeCNBC
» Subscribe to CNBC Classic: cnb.cx/SubscribeCNBCclassic
Turn to CNBC TV for the latest stock market news and analysis. From market futures to live price updates CNBC is the leader in business news worldwide.
The News with Shepard Smith is CNBC’s daily news podcast providing deep, non-partisan coverage and perspective on the day’s most important stories. Available to listen by 8:30pm ET / 5:30pm PT daily beginning September 30: www.cnbc.com/2020/09/29/the-news-with-shepard-smit…
Connect with CNBC News Online
Get the latest news: www.cnbc.com/
Follow CNBC on LinkedIn: cnb.cx/LinkedInCNBC
Follow CNBC News on Facebook: cnb.cx/LikeCNBC
Follow CNBC News on Twitter: cnb.cx/FollowCNBC
Follow CNBC News on Instagram: cnb.cx/InstagramCNBC
www.cnbc.com/select/best-credit-cards/
#CNBC
#CNBCTV
コメント (21)
-
Love the concept. CEO along with other founder Knight have me sold on the company. I can't wait to see what they accomplish in 5 to 10 years. I hold shares of DNA and will add more over time.
-
Ginkgo share are below $1.00 for a while now and every chance to get it back up to a day has fail! The company has file to issue an additional 16 million share with the SEC!
-
Bought 1000 shares at $9.88 - now just going to sit tight for 5 years and see where this goes.
-
This guy is a good talker. Not sure if he's a bullshitter yet but he definitely knows how to talk.
-
Great company and looks very promising but it has a P/S ratio of like 100 for the end of this year.
-
Wish I never bought it today (3/2/22) I’m down -67.24%
-
8/23/22 can’t break 3.00 a share, overspending and crazy compensation when they aren’t even profitable yet. Hope they can turn it around , as I’m invested in this company
-
Bought at $3 hope this is the dip or at least close lel
-
This guys is selling a great story without any actual products.
-
This is Umbrella Corp. people…. Don’t be fooled…..
-
martin shkreli 2.0
-
Great company
-
I was really interested in this company until I saw the CEO. He gives me bad vibes. He sounds like a salesman. Maybe this is a buy at 0.8 USD per share. The valuation of this stock was pure nonesense couple months ago. Definitely form over substance here.
-
that thickness mmmmmm
-
At least they are finally admitting they want to program DNA.
-
Might start a position if it hits $2.00 again
-
love the business model and the space... waiting to see if it will dip below $10 if it does I'll be buying around the $8.50 level in the coming weeks 😁
-
She is trying to catch up with him on his elaboration on biology, hahaha!! Nevertheless , he's a very smart guy!!! I will put this ipo on my radar for some time!
-
Risk to add to s1…. Zombies
-
Its a good buy under $3
